Evaxion A (EVAX) Receivables - Other (2019 - 2024)
Evaxion A (EVAX) reported Receivables - Other of $37000.0 for Q4 2024, down 65.74% on a YoY basis from $108000.0 in Q1 2024, and down 65.74% quarter-over-quarter from $108000.0 in Q4 2023.
Evaxion A (EVAX) Receivables - Other (2019 - 2024) Analysis & Trends
Evaxion A has reported Receivables - Other for 6 years, with the latest figure at $37000.0 in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other fell 65.74% year-over-year to $37000.0; the trailing twelve-month figure through Dec 2024 stood at $37000.0 (down 65.74% YoY), and the FY2024 full-year result was $37000.0, down 65.74% from the prior year.
- Receivables - Other for Q4 2024 stood at $37000.0, down from $108000.0 in the prior quarter.
- The five-year high for Receivables - Other was $113000.0 in Q4 2021, with the low at $7000.0 in Q4 2020.
- Historically, Receivables - Other has averaged $55000.0 across 5 years, with a median of $37000.0 in 2024.
- Annual changes were most pronounced in 2021 — Receivables - Other soared 1514.29% — and 2022, when it plunged 91.15%.
- Evaxion A's Receivables - Other stood at $7000.0 in 2020, then soared by 1514.29% to $113000.0 in 2021, then sank by 91.15% to $10000.0 in 2022, then jumped by 980.0% to $108000.0 in 2023, then tumbled by 65.74% to $37000.0 in 2024.
- The last three Receivables - Other figures came in at $37000.0 (Q4 2024), $108000.0 (Q4 2023), and $10000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 37,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2019 | 32,000.00 |
| Dec 31, 2019 | 32,000.00 |